Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
CNS Drugs
Erschienen in: CNS Drugs 4/2019

01.04.2019 | Therapy in Practice

Skin-Picking Disorder: A Guide to Diagnosis and Management

verfasst von: Mohammad Jafferany, Arsh Patel

Erschienen in: CNS Drugs | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Skin-picking disorder, also known as excoriation disorder or psychogenic skin excoriations, is an obsessive–compulsive and related disorder that is classified with other body-focused repetitive-behavior disorders in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Skin-picking disorder is associated with significant comorbidity and psychosocial dysfunction. The disorder has a female predominance across studies, and the average age of onset is variable but commonly in adolescence and adulthood. A full clinical and dermatologic examination and multidisciplinary approach is important in the diagnosis of this condition. There is no specific or recommended treatment option, but cognitive–behavioral therapy, particularly habit-reversal therapy and acceptance and commitment therapy have shown promise. Various pharmacological interventions have also been described to treat this condition in case reports and open and controlled trials. Specific classes of agents implemented include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors, antipsychotics, and glutaminergic-modulating agents. SSRIs and N-acetylcysteine have been shown to be the most effective of the pharmacological interventions.
Literatur
1.
Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. CNS Drugs. 2001;15(5):351–9.PubMedCrossRef
2.
Wilson E. Lectures on dermatology. Delivered in the Royal College of Surgeons of England, 1874–1875. London: J and A Churhil; 1875.
3.
Bach M, Bach D. Psychiatric and psychometric issues in acné excoriée. Psychother Psychosom. 1993;60(3–4):207–10.PubMedCrossRef
4.
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Washington DC: American Psychiatric Association. 2013.
5.
Misery L, Chastaing M, Touboul S, et al. Psychogenic skin excoriations: diagnostic criteria, semiological analysis and psychiatric profiles. Acta Derm Venereol. 2012;92(4):416–8.PubMedCrossRef
6.
Koo JYM, Lee CS. General approach to evaluating psychodermatological disorders. In: Koo JYM, Lee CS, editors. Psychocutaneous medicine. New York: Marcel Dekker, Inc.; 2003. p. 1–29.
7.
Jafferany M, Franca K. Psychodermatology: basics concepts. Acta Derm Venereol. 2016;96(217):35–7.PubMed
8.
Houghton DC, Alexander JR, Bauer CC, et al. Body-focused repetitive behaviors: more prevalent than once thought? Psychiatry Res. 2018;2(270):389–93.CrossRef
9.
Hayes SL, Storch EA, Berlanga L. Skin picking behaviors: an examination of the prevalence and severity in a community sample. J Anxiety Disord. 2009;23(3):314–9.PubMedCrossRef
10.
Keuthen NJ, Koran LM, Aboujaoude E, Large MD, Serpe RT. The prevalence of pathologic skin picking in US adults. Compr Psychiatry. 2010;51(2):183–6.PubMedCrossRef
11.
Machado MO, Köhler CA, Stubbs B, et al. Skin picking disorder: prevalence, correlates, and associations with quality of life in a large sample. CNS Spectr. 2018;23(5):311–20.PubMedCrossRef
12.
Ricketts EJ, Snorrason Í, Kircanski K, et al. A latent profile analysis of age of onset in pathological skin picking. Compr Psychiatry. 2018;87:46–52.PubMedCrossRef
13.
Gupta A, Jafferany M. Psychocutaneous disease. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Lippincott William & Wilkins; 2000.
14.
Cyr PR, Dreher GK. Neurotic excoriations. Am Fam Physician. 2001;64(12):1981–4.PubMed
15.
Lochner C, Roos A, Stein DJ. Excoriation (skin-picking) disorder: a systematic review of treatment options. Neuropsychiatr Dis Treat. 2017;14(13):1867–72.CrossRef
16.
Odlaug BL, Grant JE. Pathologic skin picking. In: Grant JE, Stein DJ, Woods DW, Keuthen NJ, editors. Trichotillomania, Skin Picking and Other Body-Focused Repetitive Behaviors. Washington, DC: American Psychiatric Publishing Inc; 2012. p. 21–41.
17.
Solley K, Turner C. Prevalence and correlates of clinically significant body-focused repetitive behaviors in a non-clinical sample. Compr Psychiatry. 2018;86:9–18.PubMedCrossRef
18.
Sampaio DG, Grant JE. Body-focused repetitive behaviors and the dermatology patient. Clin Dermatol. 2018;36(6):723–7.PubMedCrossRef
19.
Odlaug BL, Kim SW, Grant JE. Quality of life and clinical severity in pathological skin picking and trichotillomania. J Anxiety Disord. 2010;24(8):823–9.PubMedCrossRef
20.
Snorrason I, Smári J, Olafsson RP. Emotion regulation in pathological skin picking: findings from a non-treatment seeking sample. J Behav Ther Exp Psychiatry. 2010;41(3):238–45.PubMedCrossRef
21.
Flessner CA, Woods DW. Phenomenological characteristics, social problems, and the economic impact associated with chronic skin picking. Behav Modif. 2006;30(6):944–63.PubMedCrossRef
22.
Mutasim DF, Adams BB. The psychiatric profile of patients with psychogenic excoriation. J Am Acad Dermatol. 2009;61(4):611–3.PubMedCrossRef
23.
Gupta M. Body-focused repetitive behaviors (BFRB) (trichotillomania, skin picking, onychophagia) and eating disorders (ED): Preliminary findings in a nondermatologic sample. J Am Acad Dermatol. 2016;74(5):46.
24.
Neziroglu F, Rabinowitz D, Breytman A, et al. Skin picking phenomenology and severity comparison. Prim Care Companion J Clin Psychiatry. 2008;10(4):306–12.PubMedPubMedCentralCrossRef
25.
Tucker BT, Woods DW, Flessner CA, et al. The Skin Picking Impact Project: phenomenology, interference, and treatment utilization of pathological skin picking in a population-based sample. J Anxiety Disord. 2011;25(1):88–95.PubMedCrossRef
26.
Koblenzer CS, Gupta R. Neurotic excoriations and dermatitis artefacta. Semin Cutan Med Surg. 2013;32(2):95–100.PubMedCrossRef
27.
Jafferany M, Stoep AV, Dumitrescu A, Hornung RL. Psychocutaneous dis- orders: a survey study of psychiatrists’ awareness and treatment patterns. South Med J. 2010;103:1199–203.PubMedCrossRef
28.
Jafferany M, Stoep AV, Dumitrescu A, Hornung RL. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous dis- orders: results of a survey study. Int J Dermatol. 2010;49:784–9.PubMedCrossRef
29.
Franklin ME, Tolin DF. In treating trichotillomania: cognitive behavioral therapy for hair pulling and related problems. New York: Springer; 2010. p. 51.
30.
Teng EJ, Woods DW, Twohig MP. Habit reversal as a treatment for chronic skin picking: a pilot investigation. Behav Modif. 2006;30(4):411–22.PubMedCrossRef
31.
Mouton SG, Stanley MA. Habit reversal training for trichotillomania: a group approach. Cogn Behav Pract. 1999;3(1):159–82.CrossRef
32.
Lerner J, Franklin ME, Meadows EA, et al. Effectiveness of a cognitive behavioral treatment program fro trichotillomania: an uncontrolled evaluation. Behav Ther. 1998;29(1):157–71.CrossRef
33.
Van Minnen A, Hoogduin KA, Keijsers GP. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry. 2003;60(5):517–22.PubMedCrossRef
34.
Woods DW, Wetterneck CT, Flessner CA. A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania. Behav Res Ther. 2006;44(5):639–56.PubMedCrossRef
35.
Keuthen NJ, Rothbaum BO, Falkenstein MJ, et al. DBT-enhanced habit reversal treatment for trichotillomania: 3- and 6-month follow up results. Depress Anxiety. 2011;28(4):310–3.PubMedCrossRef
36.
Relaxation Shenefelt PD. meditation and hypnosis for skin disorders and procedure. In: de Luca BN, editor. Mind-body and relaxation research focus. Hauppauge: Nova Science Publishers; 2008. p. 45–63.
37.
Flessner CA, Busch AM, Heideman PW, et al. Acceptance-enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: exploring the effects of component sequencing. Behav Modif. 2008;32:579–94.PubMedCrossRef
38.
39.
Hayes SC. Acceptance and Commitment Therapy and the New Behavior Therapies: Mindfulness, Acceptance, and Relationship. In: Hayes SC, Follette VM, Linehan MM, editors. Mindfulness and acceptance: Expanding the cognitive-behavioral tradition. New York: Guilford Press; 2004. p. 1–29.
40.
Fjorback LO. Mindfulness and body distress. Dan Med J. 2012;59:B4547.PubMed
41.
42.
Schumer MC, Bartley CA, Bloch MH. Systematic review of pharmacological and behavioral treatments of skin picking disorder. J Clin Psychopharmacol. 2016;36(2):147–52.PubMedPubMedCentralCrossRef
43.
Gelinas BL, Gagnon MM. Pharmacological and psychological treatments of pathological skin-picking: a preliminary meta-analysis. J Obsessive Compuls Rel Disord. 2013;2(2):167–75.CrossRef
44.
Selles RR, McGuire JF, Small BJ. A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder. Gen Hosp Psychiatry. 2016;41:29–37.PubMedCrossRef
45.
Simeon D, Stein DJ, Gross S, et al. A double -blind trial of fluoxetine in pathological skin picking. J Clin Psychiatry. 1997;58:341–7.PubMedCrossRef
46.
Sharma H. Psychogenic excoriation responding to fluoxetine; A case report. J Indian Med Assoc. 2008;106(4):245–62.PubMed
47.
Bloch MR, Elliott M, Thompson H, et al. Fluoxetine in pathological skin picking: open label and double-blind results. Psychosomatics. 2001;42(4):314–9.PubMedCrossRef
48.
Keuthen NJ, Jameson M, Loh R, et al. Open label trial of Escitalopram treatment for pathological skin picking. Int Clin Psychopharmacol. 2007;22(5):268–74.PubMedCrossRef
49.
Arbabi M, Farnia V, Balighi K, et al. Efficiency of Citalopram in treatment of pathological skin picking: a randomized double-blind placebo controlled trial. Acta Med Iran. 2008;46(5):367–72.
50.
Kalivas J, Kalivas L, Gilman D, et al. Sertraline in the treatment of neurotic excoriations and related disorders. Arch Dermatol. 1996;132(5):589–90.PubMedCrossRef
51.
Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a case of psychogenic pruritus and neurotic excoriation. Psychother Psychosom. 2000;69:165–6.PubMedCrossRef
52.
Ravindran AV, Lapierre YD, Anisman H. Obsessive compulsive spectrum disorders:effective treatment with paroxetine. Can J Psychiatry. 1999;44:805–7.PubMedCrossRef
53.
Harris BA, Sherertz EF, Flowers FP. Improvement of chronic neurotic excoriations with oral doxepin therapy. Int J Dermatol. 1978;26:541–3.CrossRef
54.
Arnold LM, Mutasim DF, Dwight MM, et al. An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol. 1999;19(1):15–8.PubMedCrossRef
55.
56.
Roi C, Bazzano A. Improvement in skin excoriation (skin picking) with use of Risperidone in a patient with developmental diability. Pediatr Rep. 2017;9(1):6946.PubMedPubMedCentralCrossRef
57.
Christensen RC. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking. Can J Psychiatry. 2004;49(11):788–9.PubMedCrossRef
58.
Garnis-Jones S, Collins S, Rosenthal D. Treatment of self-mutilation with Olanzapine. J Cut Med Surg. 2000;4(3):161–3.
59.
Spiegel DR, Finklea L. The recognition and treatment of pathological skin picking. A potential neurobiological underpinning of the efficacy of pharmacotherapy in impulse control disorders. Psychiatry. 2009;6(2):38–42.PubMed
60.
Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive-compulsive disorder: neurobiology, pathophysiology and treatment. Phamacol Ther. 2011;132(3):314–32.CrossRef
61.
Grados MA, Atkins EB, Kovacikova GI, et al. A selective review of glutamate pharmacological therapy in obsessive compulsive and related disorders. Psychol Res Behav Manag. 2015;8:115–31.PubMedPubMedCentralCrossRef
62.
63.
Asevedo E, Mendes AC, Berk M, et al. Systemic review of N-Acetylcysteine in the treatment of addictions. Rev Bras Psiquiatr. 2014;36(2):168–75.PubMedCrossRef
64.
Grant JE, Chamberlain SR, Redden SA, et al. N-Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(5):490–6.PubMedCrossRef
65.
Silva-Netto R, Jesus G, Nogueora M, et al. N-Acetylcysteine in the treatment of skin picking disorder. Braz J Psychiatr. 2014;36(1):101.CrossRef
66.
Odlaug BL, Grant JE. N-Acetylcysteine in the treatment of grooming disorder. J Clin Psychopharmacol. 2007;27:227–9.PubMedCrossRef
67.
Grant JE, Odlaug BL, Kim SW. Lamoatrigine treatment of pathologic skin picking: an open label study. J Clin Psychiatry. 2007;68:1384–91.PubMedCrossRef
68.
Grant JE, Odlaug BL, Chamberlain SR, et al. A double-blind placebo-controlled trial of Lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010;30:396–403.PubMedPubMedCentralCrossRef
69.
70.
Bonnot O, Cohen D, Thuilleaux D, et al. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature. Eur J Periatr. 2016;175(1):9–18.CrossRef
71.
72.
Shapira NA, Lessig MC, Murphey TK, et al. Topiramate attenuate self-injurious behavior in Prader-Willi syndrome. Int J Neuropsychopharmacol. 2002;5(2):141–5.PubMedCrossRef
73.
Sasso DA, Kalanithi PS, Trueblood KV, et al. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol. 2006;26(2):685–7.PubMedCrossRef
74.
Banga A, Conner DF. Effectiveness of Naltrexone for treating pathological skin picking behavior in an adolescent with Prader-Willi syndrome. J Child Adolesc Psychopharmacol. 2012;22(5):396–8.PubMedCrossRef
75.
Benjamin E, Bout-Smith T. Naltrexone and fluoxetine in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry. 1993;32(4):870–3.PubMedCrossRef
76.
Seedat S, Stein DJ, Harvey BH. Inositol in the treatment of trichotillomania and compulsive skin picking. J Clin Psychiatry. 2001;62(1):60–1.PubMedCrossRef
77.
Jones G, Keuthen N, Greenberg E. Assessment and treatment of trichotillomania (hair pulling disorder) and excoriation (skin picking) disorder. Clin Dermatol. 2018;36:728–36.PubMedCrossRef
78.
Dunbar AB, Magid M, Reichenberg JS. Habit Reversal training for body focused repetitive behaviors. G Ital Dermatol Venereol. 2018;153(4):557–66.PubMed
Metadaten
Titel
Skin-Picking Disorder: A Guide to Diagnosis and Management
verfasst von
Mohammad Jafferany
Arsh Patel
Publikationsdatum
01.04.2019
Verlag
Springer International Publishing
Erschienen in
CNS Drugs / Ausgabe 4/2019
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI
https://doi.org/10.1007/s40263-019-00621-7

Weitere Artikel der Ausgabe 4/2019

CNS Drugs 4/2019 Zur Ausgabe

Correction

Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

Systematic Review

Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review

Original Research Article

DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment

Review Article

Expanding Role of NMDA Receptor Antagonists in the Management of Pain

Original Research Article

Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case–Control Study Using Automated Health Data Sources

Leading Article

Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise